Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome

Marta Los Arcos1, Corsino Rey, Andrés Concha

  • 1Paediatric Intensive Care Unit, Department of Paediatrics, Hospital Universitario Central de Asturias, University of Oviedo, Oviedo, Spain. martalosarcos@yahoo.es

BMC Pediatrics
|May 2, 2008
PubMed

Insights

Procalcitonin (PCT) levels measured within 24 hours after pediatric cardiac arrest can indicate mortality risk. Higher PCT levels in non-survivors suggest its utility as a prognostic marker in pediatric critical care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Biomarkers in Critical Illness
  • Cardiorespiratory Resuscitation

Background:

  • Procalcitonin (PCT) and C-reactive protein (CRP) are established infection markers.
  • PCT levels correlate with infection severity, progression, and mortality.
  • Post-cardiac arrest syndrome involves systemic inflammation and potential endotoxin tolerance.

Purpose of the Study:

  • To investigate the time-course of PCT and CRP levels following pediatric cardiac arrest.
  • To evaluate PCT and CRP as potential markers for immediate survival after pediatric cardiac arrest.

Main Methods:

  • Retrospective observational study in a university hospital PICU over two years.
  • Eleven pediatric patients (<14 years) admitted after cardiac arrest were included.
  • PCT and CRP plasma concentrations measured at 12 and 24 hours post-admission.

Main Results:

  • PCT levels rose 12 hours post-arrest in both survivors and non-survivors.
  • Non-survivors showed a significant further increase in PCT between 12 and 24 hours (median 205.5 ng/mL vs. 22.7 ng/mL in survivors, p < 0.05).
  • CRP levels were elevated in all patients, with no significant difference between survivors and non-survivors at 12 and 24 hours.

Conclusions:

  • PCT measurement within 24 hours after pediatric cardiac arrest may serve as a mortality marker.
  • PCT kinetics, particularly the rise between 12 and 24 hours, differentiate survivors from non-survivors.
  • CRP levels did not show prognostic value in this cohort.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...